What is 7-SIGMA?
7-SIGMA operates as a sophisticated designer and manufacturer of high-performance polymer and metal components. The firm distinguishes itself through an end-to-end service model that integrates design assistance, rapid prototyping, and rigorous testing protocols. Beyond its core industrial manufacturing business, the company has diversified its portfolio with 7S3 Simulation Systems, providing specialized training solutions for healthcare professionals. This dual-track approach allows 7-SIGMA to maintain a competitive edge by balancing high-volume industrial supply with high-value, specialized medical technology, ensuring robust customer relationships and consistent product quality across diverse global markets.
How much funding has 7-SIGMA raised?
7-SIGMA has raised a total of $941K across 2 funding rounds:
Debt
$350K
Debt
$591K
Debt (2020): $350K with participation from PPP
Debt (2021): $591K led by PPP
Key Investors in 7-SIGMA
PPP
Public-Private Partnership
What's next for 7-SIGMA?
With the recent influx of capital, 7-SIGMA is positioned to accelerate its strategic initiatives, likely focusing on the expansion of its manufacturing footprint and the enhancement of its R&D capabilities. The company's focus on high-performance materials suggests a roadmap centered on technological innovation and process optimization. As the firm navigates the complexities of the aerospace and medical sectors, the current financing provides the necessary liquidity to pursue operational efficiencies and potentially scale its simulation systems division. Future growth will likely be defined by the company's ability to integrate advanced manufacturing techniques while maintaining the stringent quality standards required by its enterprise-level clientele.
See full 7-SIGMA company page
